James E. Galvin

10.7k total citations · 2 hit papers
162 papers, 7.0k citations indexed

About

James E. Galvin is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, James E. Galvin has authored 162 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Psychiatry and Mental health, 35 papers in Physiology and 22 papers in Neurology. Recurrent topics in James E. Galvin's work include Dementia and Cognitive Impairment Research (99 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). James E. Galvin is often cited by papers focused on Dementia and Cognitive Impairment Research (99 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). James E. Galvin collaborates with scholars based in United States, Spain and Japan. James E. Galvin's co-authors include John C. Morris, Catherine M. Roe, Magdalena I. Tolea, Chengjie Xiong, Stella Karantzoulis, Martha Storandt, Kimberly K. Powlishta, Carl Sadowsky, J. Philip Miller and M. Coats and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

James E. Galvin

153 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The AD8

2005 800 citations James E. Galvin, John C. Morris et al. profile →
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease

2010 558 citations James E. Galvin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Galvin United States	41	3.2k	2.0k	1.1k	951	832	162	7.0k
Wayne C. McCormick United States	48	4.2k 1.3×	2.9k 1.4×	890 0.8×	1.1k 1.2×	901 1.1×	126	9.6k
Hiroko H. Dodge United States	56	4.6k 1.4×	2.3k 1.2×	625 0.5×	1.0k 1.1×	913 1.1×	262	10.0k
Anne Corbett United Kingdom	45	2.6k 0.8×	1.8k 0.9×	843 0.7×	1.0k 1.1×	455 0.5×	168	8.0k
Brenda L. Plassman United States	52	4.7k 1.5×	2.6k 1.3×	890 0.8×	1.5k 1.5×	886 1.1×	200	11.7k
Carole Dufouil France	60	4.2k 1.3×	2.0k 1.0×	1.4k 1.2×	652 0.7×	560 0.7×	171	10.4k
George T. Grossberg United States	49	3.8k 1.2×	3.0k 1.5×	794 0.7×	824 0.9×	758 0.9×	274	10.2k
Paulo Henrique Ferreira Bertolucci Brazil	33	2.7k 0.9×	1.5k 0.7×	817 0.7×	841 0.9×	458 0.6×	180	7.0k
Kjeld Andersen Denmark	35	2.5k 0.8×	1.5k 0.8×	2.0k 1.7×	728 0.8×	375 0.5×	128	7.0k
Edo Richard Netherlands	44	2.8k 0.9×	1.3k 0.7×	838 0.7×	682 0.7×	417 0.5×	199	6.5k
Chengxuan Qiu Sweden	54	4.0k 1.3×	2.8k 1.4×	825 0.7×	863 0.9×	724 0.9×	255	11.1k

Countries citing papers authored by James E. Galvin

Since Specialization

Citations

This map shows the geographic impact of James E. Galvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Galvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Galvin more than expected).

Fields of papers citing papers by James E. Galvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Galvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Galvin. The network helps show where James E. Galvin may publish in the future.

Co-authorship network of co-authors of James E. Galvin

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Galvin. A scholar is included among the top collaborators of James E. Galvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Galvin. James E. Galvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galvin, James E., et al.. (2025). The Dementia Literacy Assessment (DeLA): A novel measure of Alzheimer's disease and related disorders health literacy in diverse populations. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(1). e70054–e70054.

Galvin, James E., et al.. (2025). The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment. PLoS ONE. 20(6). e0322351–e0322351.

Galvin, James E., et al.. (2024). Cognivue Clarity characterizes mild cognitive impairment and Alzheimer’s disease in biomarker confirmed cohorts in the Bio-Hermes Study. Scientific Reports. 14(1). 24519–24519. 3 indexed citations

Besser, Lilah M., et al.. (2024). Social Determinants of Health, Risk and Resilience against Alzheimer’s Disease and Related Dementias: The Healthy Brain Initiative. Journal of Alzheimer s Disease Reports. 8(1). 637–646. 7 indexed citations

Galvin, James E., et al.. (2024). Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population. Journal of Alzheimer s Disease. 100(2). 509–523. 3 indexed citations

Ma, Da, Sieun Lee, Karteek Popuri, et al.. (2023). Predicting Alzheimer’s disease progression in healthy and MCI subjects using multi‐modal deep learning approach. Alzheimer s & Dementia. 19(S2). 1 indexed citations

Wiese, Lisa Kirk, Ishan C. Williams, Janet K. Holt, et al.. (2023). Testing the ‘Faith Moves Mountains model’ to increase Alzheimer’s disease awareness, detection, and diagnosis among rural, racially, and ethnically diverse older adults. Aging & Mental Health. 28(6). 943–956. 1 indexed citations

Boltz, Marie, Jacqueline Mogle, Rhonda BeLue, et al.. (2023). Testing an Intervention to Improve Posthospital Outcomes in Persons Living With Dementia and Their Family Care Partners. Innovation in Aging. 7(7). igad083–igad083. 7 indexed citations

Besser, Lilah M., et al.. (2023). Associations between structural/social determinants of health and vulnerability for and resilience against Alzheimer’s disease and related dementias: The Healthy Brain Initiative. Alzheimer s & Dementia. 19(S23). 1 indexed citations

10.

Boltz, Marie, Rhonda BeLue, Barbara Resnick, et al.. (2022). The Modified Caregiver Strain Index in Black and White Dementia Caregivers at Hospital Discharge. Clinical Gerontologist. 46(4). 574–584. 5 indexed citations

11.

Ma, Da, Sieun Lee, Karteek Popuri, et al.. (2022). Predicting time-to-conversion for dementia of Alzheimer's type using multi-modal deep survival analysis. Neurobiology of Aging. 121. 139–156. 17 indexed citations

12.

Butler, Tracy, Judith D. Goldberg, James E. Galvin, et al.. (2021). Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's. Contemporary Clinical Trials. 107. 106488–106488. 13 indexed citations

13.

Hssayeni, Murtadha D., et al.. (2020). Dual-Task Gait Assessment and Machine Learning for Early-detection of Cognitive Decline. PubMed. 2020. 3204–3207. 20 indexed citations

14.

Galvin, James E., et al.. (2020). The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment. PLoS ONE. 15(11). e0242233–e0242233. 35 indexed citations

15.

Pardo, Cristóbal Carnero, et al.. (2013). Assessing the diagnostic accuracy (DA) of the Spanish version of the informant-based AD8 questionnaire. SHILAP Revista de lepidopterología. 28(2). 88–94. 27 indexed citations

16.

Galvin, James E., et al.. (2012). Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease. Clinical Practice. 9(2). 199–209. 50 indexed citations

17.

Johnson, David K. & James E. Galvin. (2011). Longitudinal Changes in Cognition in Parkinson’s Disease with and without Dementia. Dementia and Geriatric Cognitive Disorders. 31(2). 98–108. 30 indexed citations

18.

Galvin, James E., Anne M. Fagan, David M. Holtzman, Mark A. Mintun, & John C. Morris. (2010). Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain. 133(11). 3290–3300. 75 indexed citations

19.

Seugnet, Laurent, James E. Galvin, Yasuko Suzuki, Laura Gottschalk, & Paul J. Shaw. (2009). Persistent Short-Term Memory Defects Following Sleep Deprivation in a Drosophila Model of Parkinson Disease. SLEEP. 32(8). 984–992. 38 indexed citations

20.

Galvin, James E., Thomas Meuser, Mary A. Coats, Donald A. Bakal, & John C. Morris. (2009). The “Portable” CDR. Alzheimer Disease & Associated Disorders. 23(1). 44–49. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact